Introduction of cyclic guanidines into cationic lipids for non-viral gene delivery
Authors:
- Marc FredericMFMarc Frederic
- Daniel SchermanDSDaniel Scherman
- Gerardo BykGBGerardo Byk
- 1 January 2000
- journal article
- research article
- Published by Elsevier in Tetrahedron Letters
- Vol. 41 (5) , 675-679
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Structural characteristics of supramolecular assemblies formed by guanidinium-cholesterol reagents for gene transfectionProceedings of the National Academy of Sciences of the United States of America, 1999
- Optimisation des plasmides et des vecteurs synthétiques pour la thérapie génique.médecine/sciences, 1999
- Novel cationic lipids for gene delivery and gene therapyExpert Opinion on Therapeutic Patents, 1998
- Synthesis, Activity, and Structure−Activity Relationship Studies of Novel Cationic Lipids for DNA TransferJournal of Medicinal Chemistry, 1998
- Novel non-viral vectors for gene delivery: Synthesis of a second-generation library of mono-functionalized poly-(guanidinium)amines and their introduction into cationic lipidsBiotechnology and Bioengineering, 1998
- Guanidinium-cholesterol cationic lipids: efficient vectors for the transfection of eukaryotic cells.Proceedings of the National Academy of Sciences, 1996
- Diamine and Triamine Analogs and Derivatives as Inhibitors of Deoxyhypusine Synthase: Synthesis and Biological ActivityJournal of Medicinal Chemistry, 1995
- A Novel Cationic Amphiphile for Transfection of Mammalian CellsBiochemical and Biophysical Research Communications, 1994
- Molecular recognition: hydrogen-bonding receptors that function in highly competitive solventsJournal of the American Chemical Society, 1993
- 790. Hydropyrimidines. Part II. A new general synthesis of substituted 1,4,5,6-tetrahydropyrimidinesJournal of the Chemical Society (Resumed), 1962